Besponsa Prices, Coupons, Copay Cards & Patient Assistance
Besponsa (inotuzumab ozogamicin) is a member of the miscellaneous antineoplastics drug class and is commonly used for Acute Lymphoblastic Leukemia.
The cost for Besponsa 0.9 mg intravenous powder for injection is around $24,465 for a supply of 1 powder for injection, depending on the pharmacy you visit. Quoted prices are for cash-paying customers and are not valid with insurance plans. This price guide is based on using the Drugs.com discount card which is accepted at most U.S. pharmacies.
Besponsa prices
Intravenous Powder For Injection
0.9 mg
Besponsa intravenous powder for injection
from $24,464.75
for 1 powder for injection
Quantity | Per unit | Price |
---|---|---|
1 | $24,464.75 | $24,464.75 |
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
Drugs.com Printable Discount Card
The free Drugs.com Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.
Print Free Discount CardNote: This is a drug discount program, not an insurance plan. Valid at all major chains including Walgreens, Target, WalMart Pharmacy, Duane Reade and 65,000 pharmacies nationwide.
Besponsa Coupons, Copay Cards and Rebates
Besponsa offers may take the form of printable coupons, rebates, savings or copay cards, trial offers, or free samples. Certain offers may be printable from a website while others may require registration, completing a questionnaire, or obtaining a sample from a medical professional.
Besponsa Pfizer Oncology Together Co-Pay Savings Program
Eligible commercially insured patients may pay as little as $0 per month with savings of up to $25,000 per year; for additional information contact the program at 877-744-5675.
- Applies to:
- Besponsa
- Number of uses:
- 12 times within calendar year
- Expires
- December 31, 2026
Form more information phone: 877-744-5675 or Visit website
Patient Assistance & Copay Programs for Besponsa
Patient assistance programs (PAPs) are typically sponsored by pharmaceutical companies and offer cost-free or discounted medicines, as well as copay programs, to individuals with low income or those who are uninsured/under-insured and meet specific criteria. Eligibility requirements for each program may vary.
Provider: Pfizer Patient Assistance Program
Eligibility requirements:- Uninsured or Underinsured
- Varies
- Not specified
- Must be residing in the US or US territory
- Pfizer also has programs that provide eligible patients with insurance, support assistance, and medicines at a savings. Contact Pfizer RxPathways for details (844-989-7284).
- Besponsa (inotuzumab ozogamicin) Vial; Single-Dose for Intravenous use
More information please phone: 866-706-2400 Visit Website
Provider: Pfizer Oncology Together
Eligibility requirements:- Contact program for details.
- At or below 300% of FPL
- FDA-approved diagnosis
- The patient must also be under treatment from a US doctor.
- Co-payment assistance, reimbursement support, and patient assistance programs are available for eligible patients.
- Besponsa (inotuzumab ozogamicin) Vial; Single-Dose for Intravenous use
More information please phone: 877-744-5675 Visit Website
Disclaimer: Medication pricing is sourced from a variety of providers. Pricing may vary significantly due to several factors including brand or generic status, insurance coverage, pharmacy choice, location, and manufacturer pricing policies. Prices are subject to change. For the most accurate and up-to-date information, always consult directly with your pharmacy or healthcare provider.
See also:
Sprycel
Sprycel is used to treat chronic myeloid leukemia and acute lymphoblastic leukemia. Learn about ...
Gleevec
Gleevec is targeted cancer therapy for specific types of leukemia (blood cancer), bone marrow ...
Ozempic
Learn about Ozempic (semaglutide) for type 2 diabetes treatment, weight management, cardiovascular ...
Adriamycin
Adriamycin is used for acute lymphoblastic leukemia, acute myeloblastic leukemia, bladder cancer ...
Otrexup
Otrexup is used for polyarticular juvenile idiopathic arthritis, psoriasis, rheumatoid arthritis
Ponatinib
Ponatinib is used to treat chronic myeloid leukemia and Philadelphia chromosome positive acute ...
Blinatumomab
Blinatumomab (Blincyto) is an injectable immunotherapy treatment that may be used to treat B-cell ...
Mercaptopurine
Mercaptopurine is used for acute lymphoblastic leukemia, autoimmune hepatitis, crohn's disease ...
Dasatinib
Dasatinib is used to treat Philadelphia chromosome-positive chronic myelogenous leukemia (CML) ...
Doxorubicin
Doxorubicin is used for acute lymphoblastic leukemia, acute myeloblastic leukemia, bladder cancer ...
More about Besponsa (inotuzumab ozogamicin)
- Check interactions
- Compare alternatives
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: miscellaneous antineoplastics
- Breastfeeding
- En español